Operating Income (Loss) in USD of 10x Genomics, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
10x Genomics, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2017 to Q3 2025.
  • 10x Genomics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$32.2M, a 22.3% increase year-over-year.
  • 10x Genomics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$91.3M, a 54.3% increase year-over-year.
  • 10x Genomics, Inc. annual Operating Income (Loss) for 2024 was -$195M, a 26.7% increase from 2023.
  • 10x Genomics, Inc. annual Operating Income (Loss) for 2023 was -$265M, a 58% decline from 2022.
  • 10x Genomics, Inc. annual Operating Income (Loss) for 2022 was -$168M, a 221% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

10x Genomics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$91.3M -$32.2M +$9.24M +22.3% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 -$101M $30.1M +$71.9M 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 -$172M -$39.3M +$22.2M +36.1% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 -$195M -$49.8M +$5.35M +9.69% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025
Q3 2024 -$200M -$41.5M +$53.3M +56.2% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 -$253M -$41.7M +$21.6M +34.1% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 -$275M -$61.5M -$9.51M -18.3% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 -$265M -$55.2M -$32.1M -139% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025
Q3 2023 -$233M -$94.8M -$54.8M -137% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024
Q2 2023 -$178M -$63.4M -$241K -0.38% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$178M -$52M -$10.3M -24.6% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q4 2022 -$168M -$23.1M -$7.27M -45.9% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025
Q3 2022 -$161M -$40M -$24.1M -152% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 -$137M -$63.1M -$52.8M -511% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 -$83.8M -$41.7M -$31.5M -309% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 -$52.3M -$15.8M +$394M +96.1% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024
Q3 2021 -$446M -$15.9M +$49.4M +75.7% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 -$495M -$10.3M +$29.1M +73.8% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$524M -$10.2M +$9.67M +48.6% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 -$534M -$410M -$402M -4969% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023
Q3 2020 -$133M -$65.3M -$56.2M -617% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 -$76.5M -$39.4M -$29.1M -280% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$47.4M -$19.9M -$16.8M -555% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$30.6M -$8.08M 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2022
Q3 2019 -$9.1M +$5.84M +39.1% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$10.4M 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$3.04M 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q3 2018 -$14.9M 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019

10x Genomics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$195M +$70.8M +26.7% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025
2023 -$265M -$97.4M -58% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025
2022 -$168M -$116M -221% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025
2021 -$52.3M +$482M +90.2% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024
2020 -$534M -$504M -1647% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023
2019 -$30.6M +$80.2M +72.4% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022
2018 -$111M -$92.4M -503% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 -$18.4M 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.